✦ LIBER ✦

Observations on severity and activity indices in a therapeutic trial of active Crohn's disease

✍ Scribed by Dr. F. T. de Dombal; A. Softley

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 617 KB
Volume: 1
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.3780010403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mapping of T1-values and Gadolinium-conc

Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn's disease: A feasibility study

✍ Karin Horsthuis; Aart J. Nederveen; Marijn-Willem de Feiter; Cristina Lavini; Pi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract ## Purpose To determine the feasibility of T1‐mapping and calculation of Gadolinium‐values in luminal Crohn's Disease (CD). ## Materials and Methods Nine patients with active CD were included. For each patient disease activity was determined, based on endoscopic and histopathological

Methotrexate for maintenance of remissio

Methotrexate for maintenance of remission in chronic active Crohn's disease: Long-term single-center experience and meta-analysis of observational studies

✍ Johannes Hausmann; Kai Zabel; Eva Herrmann; Oliver Schröder 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Background: According to current guidelines methotrexate (MTX) should be considered as a second-line immunomodulator in patients with chronic active Crohn's disease (CD) if purine analogs are not tolerated or there is a lack of efficacy. However, its therapeutic role remains controversial to the pre

Comparison of two dosing methods for ind

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial

✍ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in

Comparison of the effects of 1,25 dihydr

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

✍ Pál Miheller; Györgyi Műzes; István Hritz; Gábor Lakatos; István Pregun; Péter L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Background: Vitamin D is essential for osteopenia therapy in Crohn's disease (CD). The active form of vitamin-D (aVD) is the 1,25(OH)2D. There are no data available whether aVD or plain vitamin-D (pVD) has any advantage in managing osteoporosis in CD or has any effect on the activity of the disease

Catheter-related septic thrombosis of su

✍ J.S. Souza; A.M. Sipahi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Impacts of long-term enteral nutrition o

Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study

✍ Takayuki Yamamoto; Maki Nakahigashi; Abbi R. Saniabadi; Takashi Iwata; Yasuki Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines